2089 related articles for article (PubMed ID: 15175957)
21. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
22. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).
Furtwaengler R; Reinhard H; Leuschner I; Schenk JP; Goebel U; Claviez A; Kulozik A; Zoubek A; von Schweinitz D; Graf N;
Cancer; 2006 May; 106(10):2275-83. PubMed ID: 16596620
[TBL] [Abstract][Full Text] [Related]
23. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
Schmidt D
Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
[TBL] [Abstract][Full Text] [Related]
24. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemotherapy for patients with Wilms tumor in Malawi is feasible and efficacious.
Israëls T; Molyneux EM; Caron HN; Jamali M; Banda K; Bras H; Kamiza S; Borgstein E; de Kraker J
Pediatr Blood Cancer; 2009 Oct; 53(4):584-9. PubMed ID: 19533658
[TBL] [Abstract][Full Text] [Related]
27. [Resection of nephroblastoma: problems and complications--evaluation of the Nephroblastoma Study SIOP 9/GPOH].
Roth H; Weirich A; Ludwig R; Daum R; Zimmermann H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1078-83. PubMed ID: 9101785
[TBL] [Abstract][Full Text] [Related]
28. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
29. Surgical tactics in the treatment of malignant renal tumors in childhood.
Pýcha K; Snajdauf J; Koutecký J; Kodet R; Zítková M
Pediatr Surg Int; 1997 Feb; 12(2-3):145-7. PubMed ID: 9156843
[TBL] [Abstract][Full Text] [Related]
30. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
Ora I; van Tinteren H; Bergeron C; de Kraker J;
Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
[TBL] [Abstract][Full Text] [Related]
31. Bilateral Wilms' tumors: a single-center experience with 19 cases.
Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
[TBL] [Abstract][Full Text] [Related]
32. The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study.
Mitchell C; Jones PM; Kelsey A; Vujanic GM; Marsden B; Shannon R; Gornall P; Owens C; Taylor R; Imeson J; Middleton H; Pritchard J
Br J Cancer; 2000 Sep; 83(5):602-8. PubMed ID: 10944599
[TBL] [Abstract][Full Text] [Related]
33. [Clear cell sarcoma of the kidney. A study of 13 cases].
El Kababri M; Khattab M; El Khorassani M; Hessissen L; Kili A; Nachef MN; Cherradi N; Malihy A; Alhamany Z; Msefer-Alaoui F
Arch Pediatr; 2004 Jul; 11(7):794-9. PubMed ID: 15234374
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumor: past, present and (possibly) future.
Spreafico F; Bellani FF
Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
[TBL] [Abstract][Full Text] [Related]
35. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
36. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
[TBL] [Abstract][Full Text] [Related]
37. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
[TBL] [Abstract][Full Text] [Related]
38. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?
Hero B; Graf N; Simon T; Weirich A; Tröger J; Berthold F
Klin Padiatr; 2002; 214(4):157-61. PubMed ID: 12165895
[TBL] [Abstract][Full Text] [Related]
40. [Wilms' tumor].
Graf N
Praxis (Bern 1994); 1996 Jun; 85(23):753-61. PubMed ID: 8693243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
